Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 17;189(2):248-250.
doi: 10.1093/bjd/ljad118.

Treatment of moderate-to-severe alopecia areata in pre-adolescent children with baricitinib

Affiliations

Treatment of moderate-to-severe alopecia areata in pre-adolescent children with baricitinib

Leila Asfour et al. Br J Dermatol. .

Erratum in

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest R.D.S. is an Associate Editor of the AJD; reports being a Director and Founder of Samson Clinical Pty Ltd; participates on the pharmaceutical advisory board for Eli Lilly, Pfizer Inc. and Leo Pharmaceutical; is on the speakers bureau for AbbVie and Novartis; and is a Principal Investigator (PI) in clinical trials for Amgen, Novartis, Arcutis Biotherapeutics, Aerotech, Merck and Co., Celgene, Coherus BioSciences, Jannsen, Regeneron, MedImmune, GlaxoSmithKline, Samson Clinical, Boehringer Ingelheim, Oncobiologics, Roche, Ascend, Dermira, AstraZeneca, Akesobio, Reistone Biopharma, UCB, Sanofi, Connect, Arena, Sun Pharma, Bristol Myer Squibb and Galderma. S.E. reports being a member of the dermatology advisory board for Eli Lilly and PI in clinical trials for Pfizer Inc., AbbVie, Arena Pharmaceuticals, Boston Pharmaceuticals, Bristol-Myers Squibb, Botanix, Dermira, Eli Lilly, LEO Pharma, Novartis, Regeneron, Tigermed, Suzhou Connect Biopharmaceuticals, Janssen, Kymab Ltd, KoBiolabs and Avance Clinical. L.A., A.M., B.B., L.B. and H.R. declare no conflicts of interest.

Similar articles

Cited by

Supplementary concepts